Iovance Biotherapeutics
IOVANasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)
Market cap
$3.490 B
$7.71 -11.44%
Close of 6 Nov 2026
As of 6 Nov 2026, Iovance Biotherapeutics (IOVA) has a market capitalization of $3.49B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.
Revenue
$263.5M
#2174 by revenue
Earnings
-$391.0M
Loss-making
Shares outstanding
462,655,151
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap
All 163 →- #24Adaptive BiotechnologiesADPT$4.35B
- #25Relay TherapeuticsRLAY$3.76B
- #26Iovance BiotherapeuticsIOVA$3.49B
- #27Tarsus PharmaceuticalsTARS$3.33B
- #28Denali TherapeuticsDNLI$3.16B
What if Iovance Biotherapeutics were worth as much as…
Open the what-if tool →Where these numbers come from
Share counts and financials for Iovance Biotherapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.